NMPA accepts clinical trial application for monkeypox vaccine
chinadaily.com.cn |
Updated: 2023-07-14 19:44
Share
Share - WeChat
The National Medical Products Administration (NMPA) has, on Thursday, officially accepted the clinical trial application for the replication-deficient monkeypox vaccine developed by China National Pharmaceutical Group Corporation (Sinopharm) Beijing Institute of Biological Products.
- Deaths of four people at pickling pit a work safety accident, report says
- TCM professors treat Chinese child with chest pain on Paris-Beijing flight
- China strengthens IP protection on integrated circuit layout design
- Spider-Man's favorite Shanghai noodles
- China-India border trade through Nathu La Pass resumes
- Xixia Imperial Tombs draw summer tourists to Ningxia
